Syncope, Convulsions, and Sudden Death
While quinidine has always carried some risk to the patient, this must be balanced against the anticipated benefits of treatment. Idiosyncrasy to quinidine, with the production of urticaria, purpura (usually thrombocytopenic), and asthma, is fortunately very rare, but the side-effects of quinidine therapy known as cinchonism are common and include nausea, vomiting, diarrhoea, tinnitus and temporary deafness, and fever. This has resulted in the frequent practice of giving a small test-dose of quinidine before commencing treatment.
Although syncope is usually seen in patients who have taken quinidine for several days at least, it may appear within 30 minutes of the first dose, and peripheral vascular collapse may lead on to convulsions, coma, and death. In contrast, some patients are very tolerant of the drug, and Gold (1950) quotes a patient who took with impunity a daily dose of 4 g. for 14 years and thus consumed about 20 kg. in all. Although quinidine may be used to abolish ventricular tachycardia and fibrillation, paradoxically it can induce both these arrhythmias (Wilson and Wishart, 1926) . In addition to producing an increase in the QRS interval, quinidine may depress the sinoatrial and atrioventricular nodes, resulting in all degrees of heart-block and even ventricular asyssole (Goldman, 1951) .
The -mortality rate in patients receiving quinidine appears to be between 1 % and 4%, probably nearer the latter. Sudden collapse in patients receiving quinidine, but without evidence of embolism, was recognized by Frey (1918) , who reported respiratory paralysis responding to artificial respiration and analeptic drugs. By 1922 Levy had collected examples of five patients in whom quinidine had caused syncope due to arrest of the heart and respiration. A year later Clarke-Kennedy (1923) -reported a reaction characterized by sudden loss of consciousness, apnoea, pulselessness, and profound cyanosis occurring 16 hours after conversion to sinus rhythm. In the same year Viko, Marvin, and White (1923) reported sudden death in 6 out of 484 patients treated with quinidine. Later, Parkinson and Campbell (1929) The recent introduction of direct-current defibrillation has" confirmed that systemic embolism is an infrequent com-' plication of the re-establishment of sinus rhythm (Oram and Davies, 1964) . These attacks of syncope and convulsions have been ascribed by Thomson (1956) to depression of the central nervous system. Only in the past two years has it been realized that quinidine-induced syncope is commonly due to ventricular asystole or fibrillation (Rainier-Pope, Scbrire, Beck, and Barnard, 1962; Rolseth and Storstein. 1963; Selzer and Wray, 1964) .
During a trial of quinidine after conversion to sinus rhythm by direct-current shock, syncope occurred in three of our 16 patients. To these we have been able to add details of tree other patients who suffered syncope while receiving quind e in an attem to produce sinus rhythm; one died.
Case 1
A 40-year-old woman had undergone mitral valvotomy on 29 May 1962. Atrial fibrillation persisted and attempted conversion elsewhere with quinidine had had to be abandoned owing to tinnitus and vomiting. Conversion to sinus rhythm, using a direct-current shock-.
of 100 watt-seconds across the intact chest, was achieved on 25 May 1963. Digoxin was discontinued and quinidine 0.32 g. (5 gr.) was.
given five times a day in an attempt to maintain sinus rhythm. Two days later, three hours after the 10 p.m. dose of quinidine, a fit with syncope occurred suddenly. No pulse could be felt and apnoea was present. Within a few seconds the heart and resiration were seen by a nurse to start spontaneously. An-electrocardiogram ( Fig. 1 A) (Fig. 1 c) confirmed sinus bradycardia. The P-R interval was 0.24 second, and QRS interval only 0.08 second, and the Q-To 0.49 second. Quinidine was discontinued and recovery was uneventful.
Case 4
A 60-year-old man had had ischaemic cardiac pain and dyspnoea on exertion since 1957. Atrial fibrillation had also been present at that time, but attempted conversion elsewhere with quinidine had been unsuccessful. In addition to atrial fibrillation the electrocardiogram showed right bundle-branch block with a QRS interval of 0.14 second. In August 1963 a fibrosarcoma had been removed from the left shoulder. Conversion to sinus rhythm, with persistence of the right bundle-branch block, was achieved on 20 November 1963 with a direct-current shock of 300 watt-seconds across the intact chest. Digoxin was discontinued and quinidine, 0.32 g. (5 gr.), was given five times a day in an attempt to maintain sinus rhythm. Two days later, one hour after the 10 a.m. dose of quinidine, while having a venepuncture performed by a medical student, the patient had a fit, lost consciousness, and became pulseless. External cardiac massage and mouth-to-mouth respiration was applied at once by the medical student. Meanwhile an electrocardiogram was done and showed ventricular fibrillation (Fig. 2 A) . After eight shocks with alternating current, at voltages up to 440, atrial fibrillation was produced (Fig. 2 B) 
Dicsion
The syncopal attacks in five of these six cases (see Table) were similar in that they were sudden and unheralded, the patients having previously felt well. Of these five patients, two (Cases 1 and 4) had a fit followed by syncope, two (Cases 2 and 3) were found unconscious, and the fifth was found dead. The sixth patient had not only loss of consciousness but also recurrent fits and was in congestive cardiac failure. Of the five who survived, recovery was spontaneous and uneventful within a few minutes in three (Cases 1, 2, and 3), one had recurrent fits and hypotension (Case 6), and one (Case 4) was kept alive by external cardiac massage and mouth-tomouth respiration until electrical ventricular defibrillation could be carried out.
Causation of Syncope
The mode of onset and findings during the attacks suggest that they have a similar mechanism-namely, cardiac syncope due to ventricular asystole or fibrillation. Necropsy of the single patient who died in the attack did not reveal any evidence of embolism or of recent myocardial ischaemiafindings in keeping with cardiac syncope.
Contributory factors which have been incriminated in the production of syncope include the underlying disease causing the arrhythmia, the amount of quinidine given, the presence of congestive heart failure, the concurrent additive effect of digitalis, and the vasodepressor effect of quinidine. Since quinidine is an effective anti-arrhythmic drug, clearly it would be useful to know in which patients it is likely to induce cardiac syncope. Of 22 patients in whom syncope has been reported after quinidine therapy, 17 had rheumatic and five ischaemic or hypertensive heart disease (Rainier-Pope et Rokseth and Storstein, 1963; Selzer and Wray, 1964) . In our series the underlying cause of the atrial fibrillation was rheumatic and ischaemic heart disease and treated thyrotoxicosis. Clearly quinidine-induced syncope may occur in patients with a variety of heart diseases. It appears both from our series and from those of earlier workers that most patients with rheumatic heart disease will recover spontaneously, but those with ischaemic heart disease are not likely to. Such a finding underlines the danger of quinidine in ischaemic heart disease.
Attempts have been made to relate the syncopal attacks to the total amount of quinidine or to that given in the 24 hours preceding the attack. But Selzer and Wray (1964) found that the total dose varied from 0.9 to 22.2 g. in their eight patients, while in the two patients reported by Rainier-Pope et al. (1962) it was 4.9 g., and in the 12 patients described by Rokseth and Storstein (1963) it was 0.9 to 12.9 g. In our six patients the total dose ranged between 3.2 and 6.4 g. Selzer and Wray (1964) were able to estimate the level of quinidine in the plasma in five of their patients on the day of the attack and found in three that it was between 10 and 20 mg./litre. As these workers used a simplified method for determining the plasma-quinidine level, their results correspond to roughly twice the levels quoted by Sokolow and Ball (1956) in the 24 hours preceding the attack varied from 1.6 to 3.8 g. A simple relation between the amount of quinidine given and the chance of syncope seems most unlikely.
The presence of congestive cardiac failure can slow the rate of disappearance of quinidine from the plasma (Brown, Holzman, and Creelman, 1953) . Askey (1946) , reporting on 839 patients treated with quinidine, of whom 275 were in congestive heart failure, found that the death rate was 4% when failure was present; in the 564 patients not in failure the death rate was 1.8 %. In a series of 274 patients with atrial fibrillation treated with quinidine syncope occurred in 12, and all were in severe congestive failure (Rokseth and Storstein, 1963) . However, all of these patients had been digitalized, and we wonder whether it is necessarily the presence or failure per se which is responsible for the higher mortality when quinidine is used. Only one of our patients (Case 6) Rokseth and Storstein, 1963; Selzer and Wray, 1964) all the patients were receiving digitalis, none showed any evidence of digitalis intoxication. Surprisingly, it has been claimed (Goldman, 1960) that quinidine increases the cardiac intracellular potassium and lowers the intracellular sodium. It is certain that quinidine syncope can result without concomitant administration of digitalis. In fact, this drug was not given to our three patients in the trial 'of quinidine after conversion to sinus rhythm by a direct-current shock, and of the other three patients it was continued in only two Cases (3 and 5).
It has been shown by Ferrer, Harvey, Werko, Dresdale, Cournand, and Richards (1948) that quinidine has a strong vasodepressor action and can induce hypotension, which may be unrelated to change in rhythm, and this may perhaps be a contributory factor to syncope, especially in ambulant patients. pression and mouth-to-mouth respiration, followed, if necessary, by electrical defibrillation or pacemaking. Since the disappearance of quinidine from the plasma of patients not in failure is exponential (Brow n et al., 1963) , clearly discontinuing the drug and tiding the patient over the acute episode is all that is necessary. Bellet, Hamdan, Somlyo, and Lara 1959) have reported the successful reversal of the toxic effects of quinidine on the myocardium by the use of intravenous molar sodium lactate. It is thought to act by reducing the plasma levels of quinidine and potassium and producing an alkalosis.
Prevention of quinidine-induced syncope is difficult, since an attack may occur after only modest doses of quinidine and in the presence of low plasma-quinidine levels.
Lack of intolerance to a test dose given the day previously is no guarantee that syncope will not occur. Any alteration of pulse rate or fall in blood-pressure indicates cessation of quinidinc until the cause has been ascertained. Bedside monitoring of the electrocardiogram with an automatic device which gives an immediate auditory warning of cardiac arrest may be lifesaving.
Obviously the appearance of cardiographic abnormalities such as various grades of heart-block, including intraventricular, and ventricular extrasystoles or tachycardia, is an indication for stopping the drug.
Contrary to the opinion of Gold (1950), Rokseth and Storstein (1963) found that measurement of the QRS interval seldom gave warning of impending trouble, and in four of our five patients in whom records were available shortly after syncope it was not prolonged (see Table) . Clearly, monitoring is not feasible when quinidine is used for out-patient maintenance therapy, and the occasional fatality must be expected if the drug is so used (Brenner, Davison, and Evans, 1964) .
Conclusions
From the study of our six patients with quinidine-induced syncope, one of which was fatal, and those recently reported. we think that nowadays the use of quinidine must be seriously questioned. In the treatment of cardiac arrhythmias, particularly atrial fibrillation and flutter, there is little doubt that direct-current shock, which carries the same conversion rate and risk of embolism as quinidine, is safer (Oram and Davies, 1964) . Furthermore, its action is instantaneous, so avoiding the othcr minor but troublesome side-effects of quinidine. Unfortunately, sinus rhvthm whether induced clectrically or by quinidinc may not be permanent, and it must be admitted that there are a few patients who arc so acutely aware of their paroxysms of arrhythmia that not only their daily life but also their sleep is seriously interfered with ; they can obtain respite only from continuous oral quinidine. If quinidinc is thus used as a means of attempting to maintain sinus rhythm it carries the major hazard of ventricular asystole in fibrillation.
Summary
The features of quinidine-induced syncope are described and the causation is discussed. Six further examples, one fatal, are reported.
There is no relation between the dose employed and the likelihood of syncope, and there are no pathognomonic electrocardiographic changes which reveal that toxicity is reaching danger level. In our view there is now no indication to treat any paroxysm of arrhythmia with quinidine, and direct-current shock is strongly to be preferred, but there is a small place still for its use as a preventive of paroxysms until a safer drug is discovered.
The elective treatment of quinidine-induced syncope is external cardiac compression and mouth-to-mouth respiration, followed if necessary by electrical ventricular defibrillation by direct-current shock or by pacemaking if ventricular asystole is responsible.
We would emphasize that precautions regarding quinidine therapy, including admission to hospital, a test dose the previous day, prior digitalization, abolition of all signs of congestive heart failure prior to quinidine therapy, and cathode-ray oscilloscope bedside monitoring, may all be carried out carefully and vet the patient may suddenly and unexpectedly die.
We wish to thank Mr. M. J. McArthur, the medical student without whose prompt help one patient (Case 4) would have succumbed.
